Tech Company Financing Transactions
Syapse Funding Round
On 1/12/2016, Syapse secured $25 million in Series C financing from Ascension Ventures, Safeguard Scientifics and Social Capital.
Transaction Overview
Company Name
Announced On
1/12/2016
Transaction Type
Venture Equity
Amount
$25,000,000
Round
Series C
Investors
Ascension Ventures (Lead Investor) (Matt Hermann)
Safeguard Scientifics (Gary Kurtzman)
Social Capital (Chamath Palihapitiya)
Proceeds Purpose
Syapse has built a market-leading position in the clinical implementation of precision medicine for oncology and will use this funding round to drive the rapid expansion of its category-defining software, Syapse Precision Medicine Platform, in community health systems.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
303 2nd St. North Tower 500
San Francisco, CA 94107
USA
San Francisco, CA 94107
USA
Phone
Website
Email Address
Overview
Built on a powerful cloud-based semantic data platform, Syapse applications enable the generation and use of omics profiles in diagnosing and treating patients at diagnostic companies, research institutions, medical centers, and payers.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Ken Tarkoff
Chief Financial Officer
Fletcher Payne
Chief Marketing Officer
Thomas Brown
Chief Technical Officer
Tony Loeser
President
Jonathan Hirsch
VP - Human Resources
Michelle Kemling
VP - Product Management
Vinod Subramanian
Browse more venture capital transactions:
Prev: 1/12/2016: higi venture capital transaction
Next: 1/12/2016: Uber venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC transactions reported here are sourced from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs